BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23098910)

  • 41. α-Synuclein is a Novel Microtubule Dynamase.
    Cartelli D; Aliverti A; Barbiroli A; Santambrogio C; Ragg EM; Casagrande FV; Cantele F; Beltramone S; Marangon J; De Gregorio C; Pandini V; Emanuele M; Chieregatti E; Pieraccini S; Holmqvist S; Bubacco L; Roybon L; Pezzoli G; Grandori R; Arnal I; Cappelletti G
    Sci Rep; 2016 Sep; 6():33289. PubMed ID: 27628239
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Wild-Type Monomeric α-Synuclein Can Impair Vesicle Endocytosis and Synaptic Fidelity via Tubulin Polymerization at the Calyx of Held.
    Eguchi K; Taoufiq Z; Thorn-Seshold O; Trauner D; Hasegawa M; Takahashi T
    J Neurosci; 2017 Jun; 37(25):6043-6052. PubMed ID: 28576942
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination of alpha-synuclein immunotherapy with anti-inflammatory treatment in a transgenic mouse model of multiple system atrophy.
    Valera E; Spencer B; Fields JA; Trinh I; Adame A; Mante M; Rockenstein E; Desplats P; Masliah E
    Acta Neuropathol Commun; 2017 Jan; 5(1):2. PubMed ID: 28057080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. α-synuclein multimers cluster synaptic vesicles and attenuate recycling.
    Wang L; Das U; Scott DA; Tang Y; McLean PJ; Roy S
    Curr Biol; 2014 Oct; 24(19):2319-26. PubMed ID: 25264250
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 'Prion-like' propagation of the synucleinopathy of M83 transgenic mice depends on the mouse genotype and type of inoculum.
    Sargent D; Verchère J; Lazizzera C; Gaillard D; Lakhdar L; Streichenberger N; Morignat E; Bétemps D; Baron T
    J Neurochem; 2017 Oct; 143(1):126-135. PubMed ID: 28771723
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional cooperation of α-synuclein and VAMP2 in synaptic vesicle recycling.
    Sun J; Wang L; Bao H; Premi S; Das U; Chapman ER; Roy S
    Proc Natl Acad Sci U S A; 2019 Jun; 116(23):11113-11115. PubMed ID: 31110017
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Association between α-Synuclein and α-Tubulin in Brain Synapses.
    Amadeo A; Pizzi S; Comincini A; Modena D; Calogero AM; Madaschi L; Faustini G; Rolando C; Bellucci A; Pezzoli G; Mazzetti S; Cappelletti G
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502063
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulatory Role of TPPP3 in Microtubule Organization and Its Impact on Alpha-Synuclein Pathology.
    Oláh J; Lehotzky A; Szénási T; Berki T; Ovádi J
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of Microtubule Dynamics with Chronic Epilepsy.
    Xu X; Hu Y; Xiong Y; Li Z; Wang W; Du C; Yang Y; Zhang Y; Xiao F; Wang X
    Mol Neurobiol; 2016 Sep; 53(7):5013-24. PubMed ID: 26377107
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulated interactions of the norepineprhine transporter by the actin and microtubule cytoskeletons.
    Jeannotte AM; Sidhu A
    J Neurochem; 2008 Jun; 105(5):1668-82. PubMed ID: 18331289
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Perspective Strategies for Interventions in Parkinsonism: Remedying the Neglected Role of TPPP.
    Oláh J; Norris V; Lehotzky A; Ovádi J
    Cells; 2024 Feb; 13(4):. PubMed ID: 38391951
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sex-dependent neuronal effects of α-synuclein reveal that GABAergic transmission is neuroprotective of sleep-controlling neurons.
    Santos ABD; Thaneshwaran S; Ali LK; Leguizamón CRR; Wang Y; Kristensen MP; Langkilde AE; Kohlmeier KA
    Cell Biosci; 2023 Sep; 13(1):172. PubMed ID: 37710341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cross-talk between α-synuclein and the microtubule cytoskeleton in neurodegeneration.
    Mazzetti S; Calogero AM; Pezzoli G; Cappelletti G
    Exp Neurol; 2023 Jan; 359():114251. PubMed ID: 36243059
    [TBL] [Abstract][Full Text] [Related]  

  • 54. α-Synuclein in traumatic and vascular diseases of the central nervous system.
    Zeng H; Liu N; Liu XX; Yang YY; Zhou MW
    Aging (Albany NY); 2020 Nov; 12(21):22313-22334. PubMed ID: 33188159
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence piles Up for prion-like propagation mechanisms in synucleinopathies.
    Dehay B
    Mov Disord; 2014 Feb; 29(2):187. PubMed ID: 24395139
    [No Abstract]   [Full Text] [Related]  

  • 56. Is Multiple System Atrophy a New Prion Disorder?
    Heras-Garvin A; Wenning GK
    Mov Disord; 2016 Mar; 31(3):300. PubMed ID: 26833797
    [No Abstract]   [Full Text] [Related]  

  • 57. Harnessing GABAergic Transmission for Slow Oscillations.
    Zhan Y
    Neurosci Bull; 2016 Oct; 32(5):501-2. PubMed ID: 27576517
    [No Abstract]   [Full Text] [Related]  

  • 58. [The relevance between the import roles for alpha-synuclein in neurotransmitter release and the progress of Parkinsons disease].
    Mou Z; Yuan YH; Chen NH
    Sheng Li Ke Xue Jin Zhan; 2013 Dec; 44(6):467-70. PubMed ID: 24665751
    [No Abstract]   [Full Text] [Related]  

  • 59. Bioinformatics-based identification of key candidate genes and signaling pathways in patients with Parkinson's disease and obstructive sleep apnea.
    Tang H; Zhang K; Zhang C; Zheng K; Gui L; Yan B
    Sleep Breath; 2024 Jun; 28(3):1477-1489. PubMed ID: 38316731
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amelioration of olfactory dysfunction in a mouse model of Parkinson's disease via enhancing GABAergic signaling.
    Liu XY; Wang K; Deng XH; Wei YH; Guo R; Liu SF; Zhu YF; Zhong JJ; Zheng JY; Wang MD; Ye QH; He JQ; Guo KH; Zhu JR; Huang SQ; Chen ZX; Lv CS; Wen L
    Cell Biosci; 2023 Jun; 13(1):101. PubMed ID: 37270503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.